Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Salarius Pharmaceuticals Inc SLRX

Healthcare Biotechnology
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing treatments for parties with cancers in need of new treatment options. Its product portfolio includes seclidemstat, an oral novel small molecule inhibitor of the LSD1 enzyme and the Company's lead candidate, which is being studied as a potential treatment for pediatric cancers, sarcomas, and... see more

Recent & Breaking News (NDAQ:SLRX)

Flex Pharma Presenting at BIO CEO on February 13, 2018

Business Wire February 6, 2018

Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS

Business Wire November 28, 2017

Arnold & Havas Media, Gear Communications Awarded HOTSHOT® Creative, Media & PR Duties

PR Newswire November 27, 2017

Flex Pharma Reports Third Quarter 2017 Financial Results

Business Wire November 6, 2017

Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS

Business Wire November 6, 2017

Flex Pharma, Inc. to Host Earnings Call

Accesswire November 6, 2017

Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017

Business Wire November 2, 2017

Flex Pharma Names Dr. Roger Tung to Its Board of Directors

Business Wire October 31, 2017

Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US

Business Wire October 16, 2017

19 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  September 22, 2017

Flex Pharma Presenting at Upcoming Investor Conferences in September 2017

Business Wire September 6, 2017

Flex Pharma Reports Second Quarter 2017 Financial Results

Business Wire August 2, 2017

Investor Network: Flex Pharma, Inc. to Host Earnings Call

Accesswire August 2, 2017

Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US

Business Wire August 1, 2017

Flex Pharma Names William McVicar President and Chief Executive Officer

Business Wire July 31, 2017

Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017

Business Wire July 26, 2017

Mid-Afternoon Market Update: Crude Oil Up 3%; Seagate Shares Drop After Q4 Miss

Benzinga.com  July 25, 2017

Mid-Day Market Update: Dow Rises Over 100 Points; Team Shares Plummet

Benzinga.com  July 25, 2017

FDA Grants Fast Track Designation to Flex Pharma’s FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS

Business Wire July 25, 2017

Flex Pharma Announces Executive Leadership Transition

Business Wire June 5, 2017